Supplementary Figure 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer od Michelle L. Mierzwa (14963463)

Hasła przedmiotowe:

Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates od Evan C. Chen (15054014)

Hasła przedmiotowe:

Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates od Evan C. Chen (15054014)

Hasła przedmiotowe:

Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates od Evan C. Chen (15054014)

Hasła przedmiotowe:

Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates od Evan C. Chen (15054014)

Hasła przedmiotowe:

Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates od Evan C. Chen (15054014)

Hasła przedmiotowe:

Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates od Evan C. Chen (15054014)

Hasła przedmiotowe:

Figure S1 from Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer od Samuel Rosner (15054884)

Hasła przedmiotowe:

Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER⁺ Br... od Gary N. Schwartz (16005870)

Hasła przedmiotowe:

Supplementary Figure S2 from A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid Tumors: Two-Year Outcomes od Benjamin K. Wilke (15055112)

Hasła przedmiotowe:

Supplementary Figure S1 from A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid Tumors: Two-Year Outcomes od Benjamin K. Wilke (15055112)

Hasła przedmiotowe:

Supplementary Figure 1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovari... od Stephanie L. Wethington (16354020)

Hasła przedmiotowe:

Supplemental Figure S4 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... od Ibrahim Aldoss (15055961)

Hasła przedmiotowe:

Figure 2 from Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors od Kristoffer Staal Rohrberg (15009138)

Hasła przedmiotowe:

Figure 1 from Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors od Kristoffer Staal Rohrberg (15009138)

Hasła przedmiotowe:

Table 1 from Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors od Kristoffer Staal Rohrberg (15009138)

Hasła przedmiotowe:

Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... od Ibrahim Aldoss (15055961)

Hasła przedmiotowe:

Table 2 from Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors od Kristoffer Staal Rohrberg (15009138)

Hasła przedmiotowe:

Figure S1 from Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors od Kristoffer Staal Rohrberg (15009138)

Hasła przedmiotowe:

Table 4 from Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors od Kristoffer Staal Rohrberg (15009138)

Hasła przedmiotowe: